Scientific advances will not move the world closer to achieving global
health equity until everyone, everywhere can access them.

This resource provides information about the HIV pipeline and recently
approved antiretrovirals (ARVs) for activists working on affordability of,
and access to HIV prevention and treatment in low- and middle-income
countries (LMIC); it was designed to inform decisions about prioritizing
drugs for access strategies and campaigns.